期刊文献+

前列腺癌雄激素受体和PI3K/Akt信号通路相互作用研究进展 被引量:12

Research Progress in Interaction of Androgen Receptor and PI3K/Akt Pathway in Prostate Cancer
原文传递
导出
摘要 前列腺癌的发生、进展依赖于雄激素,因此去势手术成为治疗晚期前列腺癌的标准疗法。但是去势后大多前列腺癌最终将转化为雄激素非依赖性前列腺癌,甚至进展为激素难治性前列腺癌,使得肿瘤的进展不受低水平雄激素的影响。即使如此,大多数激素非依赖性前列腺癌,依然阳性表达雄激素受体。因而雄激素受体在前列腺癌发生发展中起着重要作用。而PI3K/Akt信号通路能够通过维持细胞生存、抑制细胞凋亡、促进细胞代谢及血管生成等促进前列腺癌进展。本综述旨在总结前人研究,阐述雄激素受体和PI3K/Akt信号通路之间相互作用关系。研究表明Akt信号通路能够正性或者负性调控AR蛋白表达、蛋白的稳定性及其转录活性,从而维持细胞的生存、代谢。而AR即可以通过基因转录途径抑制Akt活化又能通过非转录基因途径激活Akt及其下游蛋白。因此,AR和Akt信号通路相互协同促进前列腺癌的发生及其向雄激素非依赖性前列腺癌进展。 The growth of prostate cancer dependent on androgen,however most of prostate cancer may result in progression to androgen independence after ADT(androgen deprived therapy).Even so androgen receptors express in majority of androgen indepen-dent prostate cancer.Therefore androgen receptor is important in the progression of prostate cancer.The Akt signaling pathway promotes the aggressive of prostate cancer,by the maintenance of cell survival,cell metabolism and angiogenesis,inhibiting apoptosis.In this review,we described interaction between androgen receptor and the Akt signaling pathways by summarizing previous research.Akt sig-naling pathway can be positive or negative regulation of AR protein expression,and its stability and transcriptional activity,thereby maintaining cell survival,metabolism.In addition,androgens regulate the Akt pathway by both genomic and non-genomic effects.The synergy between Akt and AR signaling that is sufficient to initiate and progress native adult murine prostatic epithelium to frank carcino-ma and override the effect of androgen ablation.
出处 《现代生物医学进展》 CAS 2011年第1期180-183,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金(30600618)
关键词 雄激素受体 前列腺癌 AKT Prostate cancer Androgen receptor PI3K Akt
  • 相关文献

参考文献34

  • 1Calabro F, Steinberg CN. Current Indications for Chemotherapy in Prostate Cancer Patients[J]. Eur Urol, 2007,51 (1): 17-26. 被引量:1
  • 2Jemal A, Tiwari RC, Murray T, et al. Cancer Statistics, 2004 [J]. CA Cancer J Clin, 2004,54(1): 8-29. 被引量:1
  • 3徐志兵,王国民,孙立安,张永康.上海市市区前列腺癌发病情况调查分析[J].中国临床医学,2003,10(3):344-346. 被引量:20
  • 4那彦群主编..中国泌尿外科疾病诊断治疗指南 2007版[M].北京:人民卫生出版社,2007:401.
  • 5Culig Z, Klocker H, Bartsch G, et al. Androgen receptors in prostate cancer[J]. J Urol, 2003, 170(1), 1363-1369. 被引量:1
  • 6Murillo H, Huang H, Schmidt L, et al. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. [J]. Endocrinology, 2001,142(2): 4795-4805. 被引量:1
  • 7Malik S, Brattain, M., Ghosh, Pet al. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer [J]. Clin. Cancer Res, 2002, 8(2):1168-1171. 被引量:1
  • 8Kreisberg J, Malik S, Kreisberg S, et al. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer[J]. Cancer Res, 2004, 64(2), 5232-5236. 被引量:1
  • 9Grafr J, Konicek B, McNulty Aet al.Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kipl expression[J]. J Biol Chem, 2000, 275(2), 24500-24505. 被引量:1
  • 10Peterson R, Schreiber L,.Kinase phosphorylation: Keeping it all in the family[J]. Curr. Biol, 1999, 9(2), 521-524. 被引量:1

二级参考文献14

  • 1王涛,王润田,顾方六,王天根,冷泰俊,汪启明,黄翼然,魏强,欧阳骏,甘为民,肖正文,高居忠,庞自力,张文标,朱江,赵长林,张元芳,刘雨,张力青,宋涛,高江平,王玉杰,段国兰,陈曾德.营养素的摄入水平与前列腺癌关系的病例对照研究[J].中华泌尿外科杂志,1996,17(9):540-544. 被引量:8
  • 2刘耀庭,程伟,李秀霞.泌尿外科肿瘤发病情况的变化[J].临床泌尿外科杂志,1997,12(1):47-48. 被引量:39
  • 3Waterbor JW, Bueschen AJ. Prostate cancer screening (United States). Cancer Casues Control, 1995, 6(3) : 267-274. 被引量:1
  • 4Parker SL, Tong T, Bolden S, et 81. Cancer Statisis, CA cancer J Clin, 1997, 47: 5-27. 被引量:1
  • 5Fan Jin, Susan S, Wei Zheng, et al. Cancer incidence trends in urban shanghai. Int J Cancer, 1993, 53: 764-770. 被引量:1
  • 6Tulinius H. Latent malignancies at autopsy: a little used source of information on cancer biology. IARC Sei Publ, 1991, 112:253-261. 被引量:1
  • 7Silvestri F, Bussani R, Pavletic N, et al. Neoplastic and borderline lesion of the prostate: autopsy study and epidemiological data. Pathol Res Pratt, 1995, 191(9): 908-916. 被引量:1
  • 8Mebance C, Gibbs T, Horm J. Current status of prostate cancer in North American black males. J Nad Med Assoc, 1990, 82(11) : 782-788. 被引量:1
  • 9Demark Wahnefried W, Schildkraut JM, Iselin CE, et al.Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer, 1998, 83(2): 320-330. 被引量:1
  • 10Henrik Gronberg. Prostate cancer- epidemiological studies.Umea University: Umea University Medical Dissertations,1995, 431. 被引量:1

共引文献19

同被引文献139

引证文献12

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部